Arvinas, Inc. (ARVN) stock
ARVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$6.82+0.05 (+0.74%)
Close on Nov 17, 2026Market cap $445.93MP/E 42.6Yield –
Arvinas operating margin
Operating margin is operating income as a percentage of revenue.
Arvinas's operating margin for the twelve months ending Jun 30, 2026 was -5.7%. For fiscal 2025 it was -45.1%, against -95.0% the year before. The highest annual figure on record is -45.1% in fiscal 2025.
Annual operating margin
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -45.1% | +49.9 |
| FY2024 | Dec 31, 2024 | -95.0% | +416.5 |
| FY2023 | Dec 31, 2023 | -511.5% | −311.2 |
| FY2022 | Dec 31, 2022 | -200.3% | +151.2 |
| FY2021 | Dec 31, 2021 | -351.5% | +114.9 |
| FY2020 | Dec 31, 2020 | -466.4% | −346.6 |
| FY2019 | Dec 31, 2019 | -119.8% | +186.0 |
| FY2018 | Dec 31, 2018 | -305.8% | +20.9 |
| FY2017 | Dec 31, 2017 | -326.7% | – |
Quarterly operating margin
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 65.7% | +384.9 |
| Q1 FY2026 | Mar 31, 2026 | -409.0% | −446.8 |
| Q4 FY2025 | Dec 31, 2025 | -785.3% | −687.0 |
| Q3 FY2025 | Sep 30, 2025 | -104.5% | −45.6 |
| Q2 FY2025 | Jun 30, 2025 | -319.2% | −255.8 |
| Q1 FY2025 | Mar 31, 2025 | 37.8% | +367.1 |
| Q4 FY2024 | Dec 31, 2024 | -98.3% | +115.3 |
| Q3 FY2024 | Sep 30, 2024 | -58.9% | +78.0 |
| Q2 FY2024 | Jun 30, 2024 | -63.4% | +206.4 |
| Q1 FY2024 | Mar 31, 2024 | -329.2% | −129.2 |
| Q3 FY2023 | Sep 30, 2023 | -213.6% | −19.9 |
| Q2 FY2023 | Jun 30, 2023 | -136.9% | +57.8 |
| Q1 FY2023 | Mar 31, 2023 | -269.8% | −52.1 |
| Q4 FY2022 | Dec 31, 2022 | -200.0% | −56.9 |
| Q3 FY2022 | Sep 30, 2022 | -193.7% | +314.9 |
| Q2 FY2022 | Jun 30, 2022 | -194.7% | +749.0 |
| Q1 FY2022 | Mar 31, 2022 | -217.7% | +540.4 |
| Q4 FY2021 | Dec 31, 2021 | -143.1% | +476.9 |
| Q3 FY2021 | Sep 30, 2021 | -508.6% | −90.7 |
| Q2 FY2021 | Jun 30, 2021 | -943.6% | −482.9 |
| Q1 FY2021 | Mar 31, 2021 | -758.2% | −383.0 |
| Q4 FY2020 | Dec 31, 2020 | -620.0% | −154.2 |
| Q3 FY2020 | Sep 30, 2020 | -417.9% | −436.2 |
| Q2 FY2020 | Jun 30, 2020 | -460.8% | −2.0 |
| Q1 FY2020 | Mar 31, 2020 | -375.2% | +18.5 |
| Q4 FY2019 | Dec 31, 2019 | -465.7% | +26.8 |
| Q3 FY2019 | Sep 30, 2019 | 18.3% | +434.8 |
| Q2 FY2019 | Jun 30, 2019 | -458.7% | −208.2 |
| Q1 FY2019 | Mar 31, 2019 | -393.7% | −289.5 |
| Q4 FY2018 | Dec 31, 2018 | -492.5% | −286.2 |
| Q3 FY2018 | Sep 30, 2018 | -416.5% | −32.4 |
| Q2 FY2018 | Jun 30, 2018 | -250.5% | +152.4 |
| Q1 FY2018 | Mar 31, 2018 | -104.2% | +274.3 |
| Q4 FY2017 | Dec 31, 2017 | -206.3% | – |
| Q3 FY2017 | Sep 30, 2017 | -384.2% | – |
| Q2 FY2017 | Jun 30, 2017 | -403.0% | – |
| Q1 FY2017 | Mar 31, 2017 | -378.5% | – |
See a number that looks wrong?